Abstract: Novel silylated carboxamides of the formula (I) in which M, L, R1, R2, R3, R and A are as defined in the description, a plurality of processes for preparing these compounds and their use for controlling unwanted microorganisms, and also novel intermediates and their preparation.
Type:
Application
Filed:
March 4, 2005
Publication date:
December 20, 2007
Applicant:
BAYER CROPSCIENCE AG
Inventors:
Ralf Dunkel, Hans-Ludwig Elbe, Benoit Hartmann, Jorg Greul, Alexander Klausener, Stefan Herrmann, Ronald Ebbert, Peter Dahmen, Karl-Heinz Kuck, Ulrike Wachendorff-Neumann
Abstract: 1) Fungicidal compositions comprising: a) at least one pyridylmethylbenzamide derivative of Formula (I), in which the various radicals are as defined in the description; and b) at least one compound (II) capable of inhibiting the transport of electrons of the respiratory chain of mitochondrial ubiquinol:ferricytochrome-c oxidoreductase or complex III in phytopathogenic fungal organisms. 2) Process for curatively or preventively controlling the phytopathogenic fungi of crops, characterized in that an effective and nonphytotoxic quantity of one of these fungicidal compositions is applied to the aerial parts of plants.
Type:
Application
Filed:
July 18, 2007
Publication date:
December 20, 2007
Applicant:
BAYER CROPSCIENCE S.A.
Inventors:
David Holah, Jane Dancer, Marie-Pascale Latorse, Richard Mercer
Abstract: Processes are disclosed comprising: (a) providing a gas phase comprising hydrogen chloride and oxygen; and (b) oxidizing the hydrogen chloride with the oxygen in the presence of a catalyst comprising tin dioxide and at least one oxygen-containing ruthenium compound.
Type:
Application
Filed:
May 23, 2007
Publication date:
December 20, 2007
Applicant:
Bayer Material Science AG
Inventors:
Aurel Wolf, Jurgen Kintrup, Oliver Schluter, Leslaw Mleczko
Abstract: Use of alkyl carboxylic acid amides having formula (I): R1—CO—NR2R3, wherein R1?C3-C19-Alkyl, R2?C1-C6-alkyl and R3?H or C1-C6-alkyl, for promoting the penetration of agrochemical active substances in plants.
Type:
Application
Filed:
April 22, 2005
Publication date:
December 20, 2007
Applicant:
Bayer CropScience Aktiengesellschaft
Inventors:
Andreas Rochling, Karl Reizlein, Peter Baur
Abstract: The invention relates to a compound of the formula (I) or a salt thereof in which R1 is a radical of the formula —N(B1-D1)(B2-D2) or —N(B3-D3)-N(B4-D4) (B5-D5), or a group of the formula where B1, B2, B3, B4, B5, D1, D2, D3, D4, D5, G1, L1, U1, U2, U3, and U4 are each as defined in the specification are suitable as herbicides and crop growth regulators. The compounds (I) can be prepared by processes described in the specification, via intermediates including novel intermediates.
Type:
Application
Filed:
April 11, 2007
Publication date:
December 20, 2007
Applicant:
Bayer CropScience AG
Inventors:
Klemens Minn, Hansjorg Dietrich, Thomas Auler, Martin Hills, Heinz Kehne, Dieter Feucht
Abstract: A composite member for a vehicle body a method for manufacturing such a composite member, in particular, for a vehicle roof, with a fiber-free outer skin (12) and a fiber-reinforced support layer (16), which is deposited at the inner side of the outer skin in order to support the outer skin. The side of the support layer (16) that faces away from the outer skin (12) is provided with a fiber-reinforced reinforcing layer (18) for reinforcing the support layer. The reinforcing layer has a higher fiber concentration than the support layer.
Type:
Application
Filed:
April 18, 2005
Publication date:
December 20, 2007
Applicants:
WEBASTO AG, BAYER MATERIALSCIENCE AG
Inventors:
Detlef Mies, Frank Kiesewetter, Dirk Wegener, Jan Wokoeck
Abstract: A device for cooling hot gases (quencher) with the formation of a corrosive condensation product, which device has a pressure-resistant container and at least one corrosion-resistant internal gas guide pipe, and to a method of cooling gases that form corrosive condensation products, which method uses the mentioned device.
Type:
Application
Filed:
May 23, 2007
Publication date:
December 20, 2007
Applicant:
Bayer Material Science AG
Inventors:
Helmut Diekmann, Lutz Gottschalk, Kaspar Hallenberger, Gerhard Ruffert, Knud Werner
Abstract: The present invention relates to immunohistochemical methods to identify biomarkers. This invention relates to the use of phospho-ERK (pERK) levels in tumor cells as a biomarker for a Raf kinase inhibitor. The invention also provides methods and compositions for diagnostic assays for detecting cancer.
Abstract: The invention relates to novel fungicidallly active compound combinations of 2?-cyano-3,4-dichloroisothiazole-5-carboxanilide of the formula and the active compounds listed in the disclosure.
Abstract: A process for preparing a moisture-curable, polyether urethane containing terminal cyclic urea/reactive silane groups by reacting at an NCO:OH equivalent ratio of 1.5:1 to 2.5:1 a) a hydroxyl component containing i) a polyether containing two hydroxyl groups and one or more polyether segments, wherein the polyether segments have a number average molecular weight of at least 3000 and a degree of unsaturation of less than 0.04 milliequivalents/g, and ii) a polyether containing one hydroxyl group and one or more polyether segments having a number average molecular weight of 1000 to 15,000, with b) an isocyanate component containing i) a compound containing two isocyanate groups, and ii) a compound containing one isocyanate group, and subsequently reacting this reaction product at an equivalent ratio of isocyanate groups to isocyanate-reactive groups of 0.8:1 to 1.
Abstract: A process is disclosed comprising: (a) reacting hydrogen chloride and oxygen to form a gas mixture comprising chlorine, water, unreacted hydrogen chloride, and unreacted oxygen; (b) cooling the gas mixture to form an aqueous solution of hydrogen chloride; (c) separating at least a portion of the aqueous solution of hydrogen chloride from the gas mixture; (d) removing at least a portion of the water from the gas mixture; and (e) subjecting the gas mixture to a gas permeation such that at least a portion of the unreacted oxygen in the gas mixture is separated to form a chlorine-rich gas stream and an oxygen-containing partial stream.
Type:
Application
Filed:
May 23, 2007
Publication date:
December 13, 2007
Applicant:
Bayer Material Science AG
Inventors:
Rainer Weber, Andreas Bulan, Michel Haas, Rafael Warsitz, Knud Werner
Abstract: The present application relates to novel tetrahydrobenzo[d]azepin-2-one derivatives, processes for their preparation, their use for the treatment and/or prophylaxis of diseases, and their use for producing medicaments for the treatment and/or prophylaxis of diseases, preferably for the treatment and/or prevention of cardiovascular disorders, especially of dyslipidaemias, arteriosclerosis, restenosis and ischaemias.
Type:
Application
Filed:
February 1, 2005
Publication date:
December 13, 2007
Applicant:
Bayer HealthCare AG
Inventors:
Nils Griebenow, Timo Flessner, Michael Harter, Martin Raabe, Anja Buchmuller, Hilmar Bischoff, Peter Ellinghaus, Peter Kolkhof
Abstract: The invention provides a human PPARD which is associated with the cardiovascular diseases, infections, cancer, dermatological diseases, gastroenterological diseases, inflammation, hematological diseases, metabolic diseases, muscle-skeleton diseases, neurological diseases, urological diseases and reproduction diseases. The invention also provides assays for the identification of compounds useful in the treatment or prevention of cardiovascular diseases, infections, cancer, dermatological diseases, gastroenterological diseases, inflammation, hematological diseases, metabolic diseases, muscle-skeleton diseases, neurological diseases, urological diseases and reproduction diseases. The invention also features compounds which bind to and/or activate or inhibit the activity of PPARD as well as pharmaceutical compositions comprising such compounds.
Type:
Application
Filed:
March 20, 2005
Publication date:
December 13, 2007
Applicant:
BAYER HEALTHCARE AG
Inventors:
Stefan Golz, Ulf Bruggemeier, Andreas Geerts
Abstract: The invention provides a human DPP1 which is associated with the infections, cardiovascular diseases, respiratory diseases, cancer, endocrinological diseases, metabolic diseases, gastroenterological diseases, inflammation, hematological diseases, muscle skeleton diseases, neurological diseases and urological diseases. The invention also provides assays for the identification of compounds useful in the treatment or prevention of infections, cardiovascular diseases, respiratory diseases, cancer, endocrinological diseases, metabolic diseases, gastroenterological diseases, inflammation, hematological diseases, muscle skeleton diseases, neurological diseases and urological diseases. The invention also features compounds which bind to and/or activate or inhibit the activity of DPP1 as well as pharmaceutical compositions comprising such compounds.
Type:
Application
Filed:
April 15, 2005
Publication date:
December 13, 2007
Applicant:
BAYER HEALTHCARE AG
Inventors:
Stefan Golz, Bruggemeiere Ulf, Andeas Geerts
Abstract: The present invention relates to a process for preparing ?-fluorinated esters from ?-hydroxy esters by reaction with a dihalocarbonyl compound (or an equivalent) to give haloformates and further to give fluoroformates, which are then decomposed thermally in the presence of suitable catalysts. The invention further relates to the individual steps of the process and in some cases to novel fluoroformates.
Abstract: The present invention relates to novel polyaspartimides, their method of production and the use of these polyaspartimides as reactive components for polyisocyanates in two-component polyurethane coating compositions. The polyaspartimides are prepared by reacting a polyether amine with a maleimide.
Type:
Grant
Filed:
November 16, 2004
Date of Patent:
December 11, 2007
Assignee:
Bayer MaterialScience LLC
Inventors:
Karsten Danielmeier, Charles A. Gambino, Rolf Gertzmann, Richard R. Roesler, Terrell D. Wayt, Edward P. Squiller, Michele E. Honko, Karen Marie Henderson
Abstract: Toluenediamine is produced and separated from by-products of the reaction by: a) hydrogenating dinitrotoluene in the presence of a catalyst, b) separating the catalyst, water and optionally solvent from the hydrogenation reaction mixture to give crude toluenediamine, and c) separating by distillation the crude toluenediamine in a separating wall column into at least four product streams P1, P2, P3 and P4. The product stream P1 is a stream containing low boilers. The product stream P2 is a stream containing o-toluenediamine. The product stream P3 is a stream containing m-toluenediamine. The product stream P4 is a stream containing high boilers and m-toluenediamine.
Type:
Grant
Filed:
July 7, 2006
Date of Patent:
December 11, 2007
Assignee:
Bayer MaterialScience AG
Inventors:
Bernd Pennemann, Bill Brady, Rainer Buse, Gerd Greger
Abstract: The present invention relates to novel 3-biphenyl-substituted, 3-substituted 4-keto-lactams and -lactones of the formula (I) in which A, B, Q, G, W, X, Y and Z are as defined in the disclosure, to processes for their preparation, and to their use as pesticides and/or microbicides and/or herbicides.
Type:
Grant
Filed:
November 18, 2002
Date of Patent:
December 11, 2007
Assignee:
Bayer CropScience AG
Inventors:
Reiner Fischer, Astrid Ullmann, Thomas Bretschneider, Mark Wilhelm Drewes, Angelika Lubos-Erdelen, legal representative, Dieter Feucht, Udo Reckmann, Karl-Heinz Kuck, Ulrike Wachendorff-Neumann, Christoph Erdelen, deceased
Abstract: The present invention relates to novel human extracellular matrix polypeptides, designated RG1, polynucleotides encoding the polypeptides, methods for producing the polypeptides, expression vectors and genetically engineered host cells for expression of the polypeptides. The invention further relates to methods for utilizing the polynucleotides and polypeptides in research, diagnosis, and therapeutic applications.
Abstract: Processes are disclosed which include: (a) providing a gas comprising chlorine, oxygen, and carbon dioxide; (b) feeding the gas to a distillation column having a head, a bottom, a rectifying section and a stripping section, wherein the gas is fed to the distillation column at an introduction point between the rectifying section and the stripping section; (c) distilling the gas in the column at a pressure of 8 to 30 bar and at a column head temperature of ?10° C. to ?60° C., to form liquid chlorine and a head mixture comprising carbon dioxide and oxygen; (d) removing the liquid chlorine from the distillation column at the bottom of the column; and (e) removing a first portion of the head mixture from the head of the distillation column, and refluxing a second portion of the head mixture in the column.